- Human pathology

Home > E. Pathology by systems > Respiratory system > Lungs > ALK-associated lung adenocarcinoma

ALK-associated lung adenocarcinoma

Tuesday 2 February 2016

ALK-rearranged lung adenocarcinoma

Open references

- ALK and ROS1 as targeted therapy paradigms and clinical implications to overcome crizotinib resistance. Ye M, Zhang X, Li N, Zhang Y, Jing P, Chang N, Wu J, Ren X, Zhang J. Oncotarget. 2016 Jan 18. doi : 10.18632/oncotarget.6935 PMID: 26802023 (Free)